Hydroxyapatite crystallinity does not affect the repair of critical size bone defects

Prior research has shown that hydroxyapatite (HA) is a widely used biomaterial for bone repair due to its chemical similarity to bone mineral. However, the impact of HA crystallinity on tissue response remains unclear. Established knowledge suggests that HA's physicochemical properties influence its biological performance. No prior work had resolved whether crystallinity affects bone regeneration in critical defects. This gap motivated the current investigation into how HA granules with different crystallinity levels interact with bone tissue. The study aimed to determine if HA crystallinity correlates with bone repair outcomes. Previous findings lacked direct comparisons of HA with varying Ca/P ratios and crystallinity. This work sought to clarify the role of these properties in vivo.

The aim of this study was to assess how HA granules with different crystallinity and Ca/P ratios influence bone repair in critical-size defects. The specific problem addressed is whether HA crystallinity affects its biocompatibility and bone regeneration capacity. The motivation stems from the need to optimize HA graft materials for clinical use. This investigation sought to compare two HA types with distinct physicochemical profiles. The study focused on calvaria defects in rats to model bone healing. The goal was to determine if HA crystallinity influences tissue response. The researchers aimed to clarify whether HA crystallinity is a critical factor in bone repair. The study also sought to evaluate the biocompatibility of HA granules in vivo.

The study involved the preparation of two HA granules with distinct Ca/P ratios and crystallinity levels. HA-1 had a Ca/P ratio of 1.60 and 28% crystallinity, while HA-2 had a Ca/P ratio of 1.67 and 70% crystallinity. Both granules were implanted into critical-size calvaria defects in rats. A control group received only blood clot in the defects. Tissue response was evaluated at 1, 3, and 6 months post-implantation. Descriptive and histomorphometric analyses were conducted to assess inflammatory infiltrates and tissue volume changes. The study used macrophage-like and multinucleated giant cells as indicators of inflammation. The researchers compared the volume density of fibrous tissue and newly formed bone across groups.

The analysis revealed a mild inflammatory infiltrate, primarily composed of macrophage-like and multinucleated giant cells. Fibrous tissue volume density increased significantly (p<0.05) compared to the control group. Newly formed bone and biomaterial volume densities were similar to the control group. No significant differences were observed between HA-1 and HA-2 in terms of tissue response. Both HA types demonstrated biocompatibility and non-degradability. The Ca/P ratio and crystallinity did not influence bone repair outcomes. The findings suggest that HA crystallinity does not affect critical-size defect repair. The study showed consistent results across all time points evaluated.

The authors concluded that HA granules with different crystallinity and Ca/P ratios are biocompatible and non-degradable. The study found no evidence that crystallinity affects bone repair in critical-size defects. The results suggest that HA crystallinity is not a determining factor in tissue response. The researchers propose that both HA types are suitable for bone grafting applications. The findings support the use of HA as a reliable biomaterial regardless of crystallinity. The study did not observe any significant differences in bone regeneration between HA-1 and HA-2. The authors suggest that other properties of HA may be more relevant to clinical success. The results align with the hypothesis that HA crystallinity does not influence repair outcomes.